Acorah Software Products - Accounts Production16.0.110truetruefalsetrueNo description of principal activity28 October 202231 October 202331 October 202314448614Pharmacoevidence Private LimitedMr Barinder Singhiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure144486142022-10-27144486142023-10-31144486142022-10-282023-10-3114448614frs-bus:PrivateLimitedCompanyLtd2022-10-282023-10-3114448614frs-bus:FilletedAccounts2022-10-282023-10-3114448614frs-bus:Micro-entities2022-10-282023-10-3114448614frs-bus:EntityHasNeverTraded2022-10-282023-10-3114448614frs-bus:AuditExempt-NoAccountantsReport2022-10-282023-10-3114448614frs-bus:Director12022-10-282023-10-3114448614frs-bus:Director22022-10-282023-10-31
Registered number: 14448614
Pharmacoevidence Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2023
TaxAssist Accountants
64 Southwark Bridge Road
London
SE1 0AS
Pharmacoevidence Ltd
Balance Sheet
As At 31 October 2023
Balance Sheet
Registered number: 14448614
2023
£
Current assets
10,000
NET CURRENT ASSETS
10,000
TOTAL ASSETS LESS CURRENT LIABILITIES
10,000
NET ASSETS
10,000
CAPITAL AND RESERVES
10,000
Notes
1.General Information
Pharmacoevidence Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14448614. The registered office is 64 Southwark Bridge Road, London, SE1 0AS.
2.Average Number of Employees
Average number of employees, including directors, during the year was as follows: 1
1
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.